seekingalpha.com · 2 jul

Stryker: The Reshaped Product Portfolio Will Drive Growth

Stryker is a Dividend Aristocrat with 32 years of increases, robust cash flow, and a strong M&A-driven growth strategy. SYK's Q1 2026 results were impacted by a cybersecurity incident, but management maintained full-year guidance and expects normalization. The stock trades at ~21x 2026E EPS, below its 5-year average, suggesting undervaluation despite recent share price declines.

247wallst.com · 1 jul

Stryker Vs. Intuitive Surgical: Stryker's Joint-Replacement Moat Over Intuitive's Premium Valuation

Stryker (NYSE:SYK | SYK Price Prediction) and Intuitive Surgical (NASDAQ:ISRG) both closed the books on Q1 2026 with sharply different results.

globenewswire.com · 1 jul

Stryker to announce second quarter 2026 financial results

Portage, Michigan, July 01, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) will host a webcast at 4:30 p.m. (Eastern time) on Thursday, July 30, 2026, to discuss its second quarter 2026 financial results.

gurufocus.com · 30 jun

Stryker Corp (SYK) Stock Down 4.7% -- Now Undervalued? GF Score: 92/100

On June 30, 2026, Stryker Corp (SYK) shares fell 4.7% to a current price of $314.84. This decline comes in a challenging year where the stock has seen a year-to

zacks.com · 29 jun

Stryker (SYK) Moves 5.3% Higher: Will This Strength Last?

Stryker (SYK) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

prnewswire.com · 24 jun

Stryker partners with professional golfer Shane Lowry to spotlight the caregiver journey in joint replacement

PORTAGE, Mich., June 24, 2026 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, today announced a new partnership with Major Champion and globally recognized golfer Shane Lowry at the Travelers Championship in Cromwell, Connecticut, naming him a sponsored brand ambassador for its Joint Replacement division.

zacks.com · 22 jun

PAHC vs. SYK: Which Stock Is the Better Value Option?

Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Stryker (SYK). But which of these two companies is the best option for those looking for undervalued stocks?

benzinga.com · 18 jun

Cramer Gives Vistra His Blessing, Backs Stryker, Steers Clear Of AI-Exposed FICO

On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying Vistra Corp. (NYSE:VST), adding it “went too high. It's come back down.